Dedicated Drug-Drug Interaction (DDI) Study in Healthy Volunteers
Status:
Recruiting
Trial end date:
2022-03-01
Target enrollment:
Participant gender:
Summary
A Phase 1, Open-Label, Non-Randomized, Fixed Sequence Study to Evaluate the Steady-state
Pharmacokinetics of BLD-0409, Nintedanib and Pirfenidone when Administered Concurrently in
Healthy Volunteers